Geron Stock Alpha and Beta Analysis
| GERN Stock | USD 1.32 0.02 1.49% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Geron. It also helps investors analyze the systematic and unsystematic risks associated with investing in Geron over a specified time horizon. Remember, high Geron's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Geron's market risk premium analysis include:
Beta 2.42 | Alpha (0.14) | Risk 3.47 | Sharpe Ratio 0.0276 | Expected Return 0.0957 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Geron Backtesting, Geron Valuation, Geron Correlation, Geron Hype Analysis, Geron Volatility, Geron History and analyze Geron Performance. Geron Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Geron market risk premium is the additional return an investor will receive from holding Geron long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Geron. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Geron's performance over market.| α | -0.14 | β | 2.42 |
Geron expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Geron's Buy-and-hold return. Our buy-and-hold chart shows how Geron performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Geron Market Price Analysis
Market price analysis indicators help investors to evaluate how Geron stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Geron shares will generate the highest return on investment. By understating and applying Geron stock market price indicators, traders can identify Geron position entry and exit signals to maximize returns.
| Price Series Summation | ||
| Price Series Division | ||
| Inverse Tangent Over Price Movement | ||
| Price Ceiling Movement | ||
| Aroon Oscillator | ||
| Balance Of Power | ||
| Simple Moving Average | ||
| Parabolic SAR | ||
| Stalled Pattern | ||
| Separating Lines |
Geron Return and Market Media
The median price of Geron for the period between Tue, Oct 7, 2025 and Mon, Jan 5, 2026 is 1.27 with a coefficient of variation of 7.35. The daily time series for the period is distributed with a sample standard deviation of 0.09, arithmetic mean of 1.26, and mean deviation of 0.08. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Acquisition by Spiegel Robert J. of 180000 shares of Geron at 3.88 subject to Rule 16b-3 | 10/17/2025 |
2 | Is Geron Corporation stock a good choice for value investors - 2025 Market WrapUp Long-Term Capital Growth Strategies - newser.com | 10/24/2025 |
3 | Geron GAAP EPS of -0.03 in-line, revenue of 47.2M misses by 6.14M | 11/05/2025 |
4 | Will Geron Corporation stock extend growth story - Earnings Miss Low Drawdown Trading Techniques - newser.com | 11/18/2025 |
5 | Wall Street Turns Bullish on Geron Corporation amid Rytelo Sales Push Plans | 11/24/2025 |
6 | Geron Corporation Presents New Data at ASH 2025 Highlighting the Relationship Between Treatment-Emergent Cytopenias and Clinical Benefit of RYTELO in Lower-Risk... | 12/08/2025 |
7 | Geron to lay off a third of workforce | 12/11/2025 |
8 | Geron Corporation Presents New Data at the 67th American Society of Hematology 2025 Annual Meeting | 12/12/2025 |
9 | Bay Area biotech company, down 1.7 billion in value, lays off a third of staff | 12/15/2025 |
10 | Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635 | 12/18/2025 |
11 | Geron Trading Up 4.9 percent - Time to Buy - MarketBeat | 12/24/2025 |
12 | Acquisition by Feller Faye of 112500 shares of Geron at 1.06 subject to Rule 16b-3 | 12/26/2025 |
13 | Geron Shares Cross Above 200 Day Moving Average - Time to Sell - MarketBeat | 12/31/2025 |
About Geron Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Geron or other stocks. Alpha measures the amount that position in Geron has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 2.5K | 183.93 | 165.54 | 157.26 | PTB Ratio | 4.86 | 8.16 | 7.34 | 7.71 |
Geron Upcoming Company Events
As portrayed in its financial statements, the presentation of Geron's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Geron's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Geron's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Geron. Please utilize our Beneish M Score to check the likelihood of Geron's management manipulating its earnings.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Geron
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Geron Backtesting, Geron Valuation, Geron Correlation, Geron Hype Analysis, Geron Volatility, Geron History and analyze Geron Performance. To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Geron technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.